Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swedish Orphan Biovitrum AB

www.sobi.com

Latest From Swedish Orphan Biovitrum AB

Start-Up Quarterly Statistics: Financings Continue Quarterly Declines Despite Big Venture Deals And IPOs

A review of biopharma start-up dealmaking and financing activity from July through September 2019, based on data from Strategic Transactions. Fundraising activity fell 23% from the second to the third quarter, but start-up M&A surged, led by Vertex's acquisition of Semma. 

Financing Deals

Bavarian Nordic Transformed By GSK Vaccines Buy

Buying two vaccines for rabies and tick-borne encephalitis complements the recently approved smallpox and monkeypox vaccine Jynneos. Now the Danish firm needs to start selling them.

Vaccines Deals

Keeping Track: A Novel Approval For Fluorodopa F 18, A Tentative Approval For Vumerity, And A Missed Goal Date For Zilretta

The latest drug development news and highlights from our US FDA Performance Tracker.

US FDA Performance Tracker Approvals

AstraZeneca Q3 Preview: Oncology Portfolio Keeps Growing

AstraZeneca, which analysts said had an 'exceptional' second quarter, is expected to have also kept that momentum up in the third quarter.
Sales & Earnings Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Sobi
  • Biovitrum AB
  • Swedish Orphan Biovitrum
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Swedish Orphan Biovitrum AB
  • Senior Management
  • Guido Oelkers, PhD, CEO
    Henrik Stenqvist, CFO
    Milan Zdravkovic, MD, PhD, Head, R&D & CMO
  • Contact Info
  • Swedish Orphan Biovitrum AB
    Phone: (46) 8 697 20 00
    Tomtebodavägen 23A
    Stockholm, SE-112 76
    Sweden
UsernamePublicRestriction

Register